Nov 22 (Reuters) - Creso Pharma (CPH) :
- CRESO IS NO LONGER SUBJECT OF ASIC INVESTIGATION
- ASIC CONFIRMED TWO DIRECTORS OF CO & CFO OF CO ARE NOT PERSONS OF INTEREST IN INVESTIGATION
- BOARD DOES NOT EXPECT THAT ANY ENFORCEMENT ACTION WILL BE TAKEN AGAINST CRESO PHARMA
- ASIC'S INVESTIGATION CONCERNING TRADING IN CRESO PHARMA'S SECURITIES BY EXTERNAL PARTIES IS ONGOING
News: CPH Creso Pharma Says Is No Longer Subject Of ASIC Investigation
Add to My Watchlist
What is My Watchlist?